DarioHealth Corp. (DRIO) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, DarioHealth Corp.'s filing signal turned negative.

DarioHealth Corp. operates as a vertically integrated health intelligence platform, aiming to drive behavior change for improved health outcomes. The company differentiates itself by owning the entire value chain in chronic care management, encompassing FDA-cleared hardware devices for continuous physiological data, AI built on proprietary data, and a behavior change and coaching layer validated by over 100 clinical studies. DarioHealth's whole-person health model addresses chronic conditions like diabetes, hypertension, and obesity, alongside behavioral health needs such as stress, anxiety, and depression. The company serves four primary market segments: direct-to-consumer (D2C), medium-to-large employers, health plans, and pharmaceutical companies, with B2B segments now representing three-fourths of its revenue. Its business model is primarily subscription-based, priced on a per member per month (PMPM) or per engaged member per month (PEMPM) basis, often including milestone-based payments and performance guarantees.

DarioHealth generates revenue primarily through subscription fees for its digital health engagement platform, offered on a per member per month (PMPM) or per engaged member per month (PEMPM) basis. These subscriptions are sold to employers, health plans, and pharmaceutical companies, and also directly to consumers.